Transcript Slide 1

Friday, December 5th, 2008
 The
patient was appropriately resuscitated
with crystalloid fluid and blood products
 Emergent
endoscopy showed large gastric
and esophageal varices with stigmata of
recent bleeding. No endoscopic therapies
or biopsies were performed at the time.
 Once
stable, a three-phase abdominal CT
with IV contrast was performed. A
diagnostic test/procedure was then
performed.
Dr. Emma Robinson
Dr. Gerald Villanueva
Department of Medicine
Division of Gastroenterology
Dr. Sameer Dhalla
 Stool
Culture: Negative
 Fecal Leukocytes: Negative
 Stool Ova and Parasites: Negative
 Hepatitis Serologies: Negative
 ANA, AMA: Negative
 Ceruloplasmin, anti-trypsin: WNL
 Tests for Thrombophilia: All Negative
 Anti-Schistosomal Antibodies: Negative
A
diagnostic liver biopsy was performed
Dr. Cristina Hajdu
Findings

MINIMAL PORTAL AND LOBULAR INFLAMMATION

FOCAL PORTAL, PERIPORTAL AND PERICENTRAL VEIN FIBROSIS

MINIMAL MACROVESICULAR STEATOSIS
Final Diagnosis
Idiopathic Portal Fibrosis
Idiopathic Portal
Fibrosis
 Young
previously healthy man from Hong
Kong with short history of heavy alcohol
use presents with UGIB and hypovolemia
 Anemia and Hypoalbuminemia
 Clinical and radiographic evidence of
portal hypertension: variceal bleed,
ascites, Splenomegaly. All out of
proportion to mild hepatocellular disease
 No cirrhosis on CT. No venous thrombosis
Intrahepatic
Prehepatic
Portal vein thrombosis
Splenic vein thombosis
Splanchnic arteriovenous
fistula
Splenomegaly (lymphoma,
Gaucher's disease)
Posthepatic
IVC obstruction
Cardiac disease
(constrictive pericarditis,
restrictive cardiomyopathy)
Presinusoidal
Schistosomiasis
Idiopathic portal hypertension/Noncirrhotic
portal fibrosis/Hepatoportal sclerosis
Primary biliary cirrhosis
Sarcoidosis
Congenital hepatic fibrosis
Sclerosing cholangitis
Hepatic arteriopetal fistula
Sinusoidal
Arsenic poisoning
Vinyl chloride toxicity
Vitamin A toxicity
Nodular regenerative hyperplasia
Postsinusoidal
Sinusoidal obstruction syndrome (Venoocclusive disease)
Budd-Chiari syndrome
Intrahepatic
Prehepatic
Portal vein thrombosis
Splenic vein thombosis
Splanchnic arteriovenous
fistula
Splenomegaly (lymphoma,
Gaucher's disease)
Posthepatic
IVC obstruction
Cardiac disease
(constrictive pericarditis,
restrictive cardiomyopathy)
Presinusoidal
Schistosomiasis
Idiopathic portal hypertension/Noncirrhotic
portal fibrosis/Hepatoportal sclerosis
Primary biliary cirrhosis
Sarcoidosis
Congenital hepatic fibrosis
Sclerosing cholangitis
Hepatic arteriopetal fistula
Sinusoidal
Arsenic poisoning
Vinyl chloride toxicity
Vitamin A toxicity
Nodular regenerative hyperplasia
Postsinusoidal
Sinusoidal obstruction syndrome (Venoocclusive disease)
Budd-Chiari syndrome
 Historical
19th century term was Banti’s
Syndrome: Anemia, thrombocytopenia,
splenomegaly without hematological cause
 Characterized
simultaneuosly in the 1960’s
-India (1962): Non-Cirrhotic Portal Fibrosis
-Japan (1962): Idiopathic Portal hypertension
-US (1965): Hepatoportal Sclerosis
 After
30 years of competing names for the
same disease, the above term has been
“generally” adopted
 Presence
of portal hypertension
 Absence of liver cirrhosis
 Histological features of dense portal
fibrosis, marked phlebosclerosis, and
dilated sinusoids.
 Present
worldwide but most focused in
South Asia and East Asia, particularly
Japan
 Prevalence: 25-30% of non-cirrhotic
portal hypertension in Asia. Dramatic
decline in a more recent Japanese
population survey.
 Disparate Male to Female Ratios
 Recurrent
Infection
 Autoimmunity
 Genetic: HLA-DR3
 Hypercoagulability
 HAART
 Miscellaneous Toxins
 Variceal
Bleed which is surprisingly well
tolerated
 Other signs of portal hypertension
 Preserved Liver Function
 Characteristic Hemodynamics
 Characteristic Path Findings
 Diagnosis
of exclusion
Frequency,
percent
Histological feature*
Irregular intimal thickening of portal veins
75-100
Organizing thrombus and/or recanalization of portal
veins
20-100
Intralobular fibrous septa
95
Abnormal blood vessels in the lobules
75
Subcapsular atrophy
70
Dense portal fibrosis and portal venous obliteration
32-52
Periductal fibrosis of interlobular bile ducts
50
Portal inflammation
Nodular hyperplasia of parenchyma
47
25-40
 Few
studies of IPF management exist
 Acute and Prophylactic regimens for
variceal bleed as with cirrhotics
 TIPS and surgical anastomosis is often
well tolerated
 Small
subgroup progress to nodular
transformation of the liver with extensive
subhepatic and portal fibrosis
 HCC?
 The
Patient is doing well on his previous
regimen of nadolol and esomeprazole
 Furosemide and Aldactone were added
for ascites
 He is following regularly with a
gastroenterologist and has had no
recurrent bleeding events since his
discharge in October 2008
Raised in
Endemic
Area
Unknown
Mechanisms
Idiopathic
Portal
Fibrosis
Alcohol
Abuse
Steatosis
and Mild
pericentral
vein
fibrosis
Asian
Descent
Medication
non-adherence
Mild Elevation in
Alk Phos and ALT
Portal
Hypertension
Gastric/Esophageal
Varices complicated by
recurrent UGIB
Ascites
Splenomegal
y
Multifactorial
Anemia
Orthostasis
 Dr. Martin
Blaser
 Dr. Anthony Grieco
 Dr. Emma Robinson
 Dr. Gerald Villanueva
 Dr. Cristina Hajdu
 Dr. Chirayu Gor
 Dr. Christina Yoon